Science

Articles

• AD/PD 2019​ International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders in LISBON
  28 January 2019, by Jonathan NOWAK

  Marion DAVID and Romy COHEN will present the “Development of vectors that cross the blood brain barrier to enhance CNS drug delivery in neurodegenerative diseases” in session A: β-Amyloid Diseases poster n°ADPD9-1832

• Vect-Horus validates the potential of its peptide vectors to transport proteins or antibodies, across the blood-brain barrier via receptor mediated transport
  28 January 2019, by Jonathan NOWAK

  (Molino et al., 2017, The FASEB Journal)
  www.fasebj.org/content/early/2017/01/19/fj.201600827R.abstract

• Meet Vect-Horus at 3rd Oligonucleotides for CNS Summit in Boston June 6-8th, 2023
  30 June 2023, by Elodie DORMES

  Meet with Michel KHRESTCHATISKY and Guillaume JACQUOT at the 3rd Oligonucleotides for CNS Summit 2023, dedicated to optimizing antisense and RNA chemistry for brain delivery, in Boston from June 6-8th, 2023.

• Vect-Horus will attend the Biorezo “Nouvelles technologies de vectorisation, perspectives pour les biotechs et pharma”
  18 October 2022, by Elodie DORMES

  We are pleased to announce that Marion DAVID will be giving a talk entitled “Développement de vecteurs moléculaires pour l’adressage ciblé de molécules d’intérêt thérapeutique” during the Biorezo organized by Eurobiomed in Toulouse on October 18th.

• TIDES Asia, March 2-5 2021 - 100% Virtual
  4 March 2021, by Elodie DORMES

  Guillaume JACQUOT PharmD, PhD, will present last company results on extra-hepatic delivery of oligonucleotides.

• Vect-Horus participates to the event Radiopharmaceuticals & Imaging on March 14, 2023
  9 March 2023, by Elodie DORMES

  Cedric MALICET, Oncology Department Manager, will participate to the Radiopharmaceuticals & Imaging event next week ! You can book a meeting with him directly via the partnering system to discuss company developments on its theranostic agents.

• Séminaire M&M’s – Muscle Monday Seminars of the Institute’s Myology Centre for Research on January 17, 2022
  17 January 2022, by Elodie DORMES

  Michel Khrestchatisky (CNRS Research Director, Director of the Institute for Neurophysiopathology) Co-Founder & Scientific Counsel of Vect-Horus presents "Development of molecular vectors for targeted delivery of RNAi via receptor-mediated transport" at the Muscle Monday Seminars organized by the Institute’s Myology Centre for Research.

• Society for the study of Blood-Brain interfaces SEISC 2019 congres
  27 November 2019, by Elodie DORMES

  Stéphane GIRARD will present iPS cell-derived model of the human blood-brain-barrier on Friday 15, Nov Session 1 of the Society for the study of Blood-Brain interfaces SEISC 2019 congres in Paris

• AAT-AD/PD Focus Meeting, TORINO Italy
  28 January 2019, by Jonathan NOWAK

  Meet Marion DAVID Vect-Horus’ Vector Discovery platform Manager during the AAT-AD/PD Focus Meeting.
  This Alzheimer’s disease conference and Parkinson’s disease conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
  More informations

• Vect-Horus strengthens its scientific advisory board with the appointment of Frédéric MATONTI
  16 May 2022, by Elodie DORMES

  Vect-Horus extends its Scientific Advisory Board with the expertise of Frédéric Matonti, a Leading Ophthalmology Specialist.